News | July 28, 2021
Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
The US business faced price erosion due to increased competition.
It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
